0001144204-13-009396.txt : 20130214 0001144204-13-009396.hdr.sgml : 20130214 20130214172819 ACCESSION NUMBER: 0001144204-13-009396 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130214 DATE AS OF CHANGE: 20130214 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SELTZER REUBEN CENTRAL INDEX KEY: 0001142334 FILING VALUES: FORM TYPE: SC 13G/A SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC CENTRAL INDEX KEY: 0000887497 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112638720 STATE OF INCORPORATION: NY FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-43074 FILM NUMBER: 13616308 BUSINESS ADDRESS: STREET 1: 369 BAYVIEW AVENUE CITY: AMITYVILLE STATE: NY ZIP: 11701 BUSINESS PHONE: 5167898228 MAIL ADDRESS: STREET 1: 369 BAYVIEW AVE. CITY: AMITYVILLE STATE: NY ZIP: 11701 SC 13G/A 1 v335236_sc13ga.htm SC 13G/A

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 11)*

 

HI-TECH PHARMACAL CO., INC.
 
(Name of Issuer)
 
COMMON STOCK
 
(Title of Class of Securities)
 
42840B101
 
(CUSIP Number)
 
December 31, 2012
 
 
(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 7 pages

 

 
 

 

 
CUSIP No. 42840B101 13G Page 2 of 7 Pages

 

1.

 

Name of Reporting Persons I.R.S. Identification Nos. of Above Persons (entities only):

  Reuben Seltzer

 

2.

 

Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)
  (b)                  Not applicable

 

3.

 

SEC Use Only

 

4.

 

Citizenship or Place of Organization: United States

 

NUMBER OF SHARES

 

BENEFICIALLY

 

OWNED BY EACH

 

REPORTING PERSON

 

WITH

 

 

5.

 

Sole Voting Power

694,010

 

6.

 

Shared Voting Power

651,089 (1)

 

7.

 

Sole Dispositive Power

694,010

 

8.

 

Shared Dispositive Power

651,089 (1)

 

9.

 

Aggregate Amount Beneficially Owned by Each Reporting Person

  996,568

 

10.

 

Check if the Aggregate Amount in Row (9)

  Excludes Certain Shares (See Instructions)                x

 

11.

 

Percent of Class Represented by Amount in Row (9)

  7.3%

 

12.

 

Type of Reporting Person (See Instructions) IN

         

 

(1) Amount includes an aggregate of 348,531 shares held in trusts for the benefit of Mr. Reuben Seltzer’s mother, which Mr. Reuben Seltzer, as trustee, has shared power to vote and dispose together with Mr. David Seltzer and Mrs. Miriam Seltzer. These shares are also reported on Mr. David Seltzer’s Schedule 13G. Mr. Reuben Seltzer disclaims beneficial ownership of such shares.

 

 
 

 

CUSIP NO. 42840B101 13G Page 3 of 7 Pages

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

(Amendment No. 11)

 

Under the Securities Exchange Act of 1934

 

HI-TECH PHARMACAL CO., INC.

(Name of Issuer)

 

Item 1(a)

 

Name of Issuer: Hi-Tech Pharmacal Co., Inc.

 

Item 1(b)

 

Address of Issuer’s Principal Executive Offices: 369 Bayview Avenue, Amityville, New York 11701

 

Item 2(a)

 

Name of Person Filing: Reuben Seltzer

 

Item 2(b)

 

Address of Principal Business Office or, if none, Residence: 369 Bayview Avenue, Amityville, New York 11701

 

Item 2(c)

 

Citizenship: United States

 

Item 2(d)

 

Title of Class of Securities: Common Stock

 

Item 2(e)

 

CUSIP Number: 42840B101

  

 
 

 

CUSIP NO. 42840B101 13G Page 4 of 7 Pages

 

Item 3

 

If this statement is filed pursuant to '240.13d-1(b) or 240.13d-2(b) or (c), check whether the person is a:

 

(1)     ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).

 

(2)     ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

(3)     ¨ Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(4)     ¨    Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

 

(5)     ¨    An investment adviser in accordance with §240.13d-1(b)(1) (ii)(E).

 

(6)     ¨    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

 

(7)     ¨    A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G).

 

(8)     ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).

 

(9)     ¨    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).

 

(10)   ¨    Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

Not applicable

 

 
 

 

CUSIP NO. 42840B101 13G Page 5 of 7 Pages

 

Item 4

 

Ownership:

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount Beneficially Owned:
    996,568

 

  (b) Percent of Class:
    7.3%

 

  (c) Number of shares as to which the person has:  
       
    (i)    Sole power to vote or to direct the vote 694,010
    (ii)  Shared power to vote or to direct the vote 651,089 (1)
    (iii) Sole power to dispose or to direct the disposition of 694,010
    (iv) Shared power to dispose or to direct the disposition of 651,089 (1)

 

 

(1) Amount includes an aggregate of 348,531 shares held in trusts for the benefit of Mr. Reuben Seltzer’s mother, which Mr. Reuben Seltzer, as trustee, has shared power to vote and dispose together with Mr. David Seltzer and Mrs. Miriam Seltzer. These shares are also reported on Mr. David Seltzer’s Schedule 13G. Mr. Reuben Seltzer disclaims beneficial ownership of such shares.

 

Item 5

 

Ownership of Five Percent or Less of a Class:

 

Not applicable

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨.

 

Item 6

 

Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable

 

Item 7

 

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

Not applicable

 

 
 

 

CUSIP NO. 42840B101 13G Page 6 of 7 Pages

 

Item 8

 

Identification and Classification of Members of the Group.

 

Not applicable

 

Item 9

 

Notice of Dissolution of Group.

 

Not applicable

 

Item 10

 

Certification.

 

Not applicable

 

 
 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 14, 2013  
   
  /s/Reuben Seltzer
  Reuben Seltzer